Scott A. Smith

2014

In 2014, Scott A. Smith earned a total compensation of $3.3M as President, Immunology & Inflammation at Celgene.

Compensation breakdown

Non-Equity Incentive Plan$719,941
Option Awards$1,141,664
Salary$546,246
Stock Awards$837,784
Other$22,238
Total$3,267,873

Smith received $1.1M in option awards, accounting for 35% of the total pay in 2014.

Smith also received $719.9K in non-equity incentive plan, $546.2K in salary, $837.8K in stock awards and $22.2K in other compensation.

Rankings

In 2014, Scott A. Smith's compensation ranked 2,741st out of 13,032 executives tracked by ExecPay. In other words, Smith earned more than 79.0% of executives.

ClassificationRankingPercentile
All
2,741
out of 13,032
79th
Division
Manufacturing
975
out of 4,966
80th
Major group
Chemicals And Allied Products
307
out of 1,686
82nd
Industry group
Drugs
239
out of 1,365
83rd
Industry
Pharmaceutical Preparations
196
out of 1,043
81st
Source: SEC filing on April 28, 2016.

Smith's colleagues

We found six more compensation records of executives who worked with Scott A. Smith at Celgene in 2014.

2014

Robert Hugin

Celgene

Chief Executive Officer

2014

Peter Kellogg

Celgene

Chief Financial Officer

2014

Jacqualyn Fouse

Celgene

President Hematology and Oncology

2014

Mark Alles

Celgene

Chief Operating Officer

2014

Thomas Daniel

Celgene

Chairman

2014

Perry Karsen

Celgene

Chief Executive Officer

You may also like